Becker's Healthcare April 12, 2021
Here are seven reimbursement updates for ASCs from the first quarter:
1. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced Jan. 21.
2. CMS released a notice March 17 that it was walking back four telehealth service codes that the agency said were inadvertently included on its final list because of technical errors.
3. CMS delayed a final rule that aims to speed up the FDA approval process for Medicare coverage of new medical devices and technologies.
4. CMS has approved ASCs as a site of service for transcervical uterine fibroid ablation — a minimally invasive procedure for symptomatic uterine fibroids that can...
Today's Sponsors
Today's Sponsor